Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 14, 2014; 20(26): 8407-8415
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8407
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8407
Nonalcoholic fatty liver disease and cardiovascular disease
Hong Liu, Hong-Yun Lu, Department of Endocrinology and Metabolism, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China
Author contributions: Liu H and Lu HY equally contributed to this paper.
Correspondence to: Dr. Hong-Yun Lu, Department of Endocrinology and Metabolism, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China. luhongyun2013@163.com
Telephone: +86-756-2528741 Fax: +86-756-2528210
Received: October 26, 2013
Revised: January 4, 2014
Accepted: April 8, 2014
Published online: July 14, 2014
Processing time: 260 Days and 19.2 Hours
Revised: January 4, 2014
Accepted: April 8, 2014
Published online: July 14, 2014
Processing time: 260 Days and 19.2 Hours
Core Tip
Core tip: The link between nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) should be carefully evaluated in future research, which represents an intriguing field of investigation. A better understanding of the role of inflammation, oxidative stress, and insulin resistance, among other mechanisms, may be necessary to clarify the pathogenesis of NAFLD and CVD, and thereby contribute to the development of new therapies.